RxDoctor Payments DataLook up a doctor →

Stella Lee

Otolaryngology · Pittsburgh, PANPI 1851573893

Payments from drug & device makers

$825,492in general payments, 2019–2025

Across 286 payments — averaging $2886.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$334K
  • Sanofi$221K
  • GSK$70K
  • Sanofi-aventis U.S. LLC$70K
  • Sanofi US Services Inc.$34K
  • Regeneron Healthcare Solutions, Inc.$34K
  • plus $63K from 12 others
$65,429in research payments, 2019–2025

Across 102 payments — averaging $641.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi$27K
  • F. Hoffmann-la Roche AG$24K
  • Sanofi-aventis U.S. LLC$12K
  • Merz North America, Inc.$1K
  • Regeneron$982

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$825,492 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$180,348
Medicare patients
232
Services billed
878

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →